Loading chat...
CO SB066
Bill
AI Summary
-
Colorado Department of Public Health and Environment must contract with opioid antagonist medication distributors for bulk purchasing and distribution of FDA-approved opioid antagonists (e.g., naloxone)
-
Distributors are prohibited from receiving state contracts if they were found liable, settled claims, or paid fines/penalties related to manufacturing or distributing opioids that resulted in overdose events
-
The prohibition extends to any division, subsidiary, parent, affiliate, or related entity under common ownership or control of a company with opioid liability
-
Department must implement a competitive selection process under the state Procurement Code, with distributors required to demonstrate eligibility and department required to verify compliance
-
Any contract violating these requirements is void and unenforceable as contrary to state public policy; selection process records become public after contract award
Legislative Description
State Contracts with Opioid Antagonist Businesses
Public Health
Last Action
Senate Committee on Health & Human Services Postpone Indefinitely
2/26/2025